Back
AbCellera Biologics Vs. Acasti Pharma Industry Stock Comparison
Sell
50
ABCL
AbCellera Biologics
Last Price:
3.78
Seasonality Move:
0.41%
Sell
35
ACST
Acasti Pharma
Last Price:
2.89
Seasonality Move:
9.22%
Sell
50
AbCellera Biologics (ABCL)
is a Sell
Is AbCellera Biologics a Buy, Sell or Hold?
- The current AbCellera Biologics [ABCL] share price is $3.78. The Score for ABCL is 50, which is 0% below its historic median score of 50, and infers higher risk than normal.
- ABCL is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
35
Acasti Pharma (ACST)
is a Sell
Is Acasti Pharma a Buy, Sell or Hold?
- The current Acasti Pharma [ACST] share price is $2.78. The Score for ACST is 35, which is 30% below its historic median score of 50, and infers higher risk than normal.
- ACST is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
ABCL Stock Price Chart
What is AbCellera Biologics's stock price today?
-
The AbCellera Biologics share price today is $3.78
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ABCL is experiencing selling pressure, which indicates risk of future bearish movement.
ACST Stock Price Chart
What is Acasti Pharma's stock price today?
-
The Acasti Pharma share price today is $2.78
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ACST is experiencing slight selling pressure.
ABCL Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.23 | Sell |
| Relative Strength Index (14 RSI): | 36.1 | Sell |
| Chaikin Money Flow: | -534941 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (3.89 - 4.47) | Sell |
| Bollinger Bands (100): | (4.38 - 5.5) | Sell |
ACST Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.14 | Sell |
| Relative Strength Index (14 RSI): | 28.56 | Sell |
| Chaikin Money Flow: | -3633 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (2.94 - 3.46) | Sell |
| Bollinger Bands (100): | (2.42 - 3.36) | Sell |
ABCL Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 3.85 | Sell |
| 20-day SMA: | 4.12 | Sell |
| 50-day SMA: | 4.52 | Sell |
| 200-day SMA: | 5.08 | Sell |
| 8-day EMA: | 3.86 | Sell |
| 20-day EMA: | 4.07 | Sell |
| 50-day EMA: | 4.42 | Sell |
| 200-day EMA: | 5.34 | Sell |
ACST Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 2.85 | Sell |
| 20-day SMA: | 3.15 | Sell |
| 50-day SMA: | 3.29 | Sell |
| 200-day SMA: | 2.61 | Buy |
| 8-day EMA: | 2.88 | Sell |
| 20-day EMA: | 3.06 | Sell |
| 50-day EMA: | 3.11 | Sell |
| 200-day EMA: | 2.92 | Sell |
AbCellera Biologics Earnings Growth & ABCL Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.03 per share, a decrease next quarter of $0.03 per share, a decrease this year of $0.18 per share, and a decrease next year of $0.05 per share.
Acasti Pharma Earnings Growth & ACST Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.08 per share, an increase next quarter of $0.07 per share, an increase this year of $1.16 per share, and an increase next year of $0.34 per share.
AbCellera Biologics Technical Analysis
| Apr 17 | Apr 18 | Apr 19 | Apr 22 | Apr 23 | Apr 24 | Apr 25 | Apr 26 | Apr 29 | Apr 30 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | ||||||||||
| 17 | 18 | 19 | 22 | 23 | 24 | 25 | 26 | 29 | 30 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Acasti Pharma Technical Analysis
| Apr 17 | Apr 18 | Apr 19 | Apr 22 | Apr 23 | Apr 24 | Apr 25 | Apr 26 | Apr 29 | Apr 30 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | ||||||||||
| 17 | 18 | 19 | 22 | 23 | 24 | 25 | 26 | 29 | 30 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||